BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Introduction Mobile health (mHealth) technologies have become increasingly popular for monitoring mental health symptoms and lifestyle behaviours, and are largely reported to be feasible and ...

This article shares a list of top Journalism and Mass Communication colleges in India for 2026, along with their courses, ...

The recruitment landscape of 2026 is no longer defined by the frantic, high-volume hiring of the early 2020s, but by a sophisticated focus on "Agentic AI" and precision matching. Founders and talent ...

From McKinsey & Company to Boston Consulting Group, AI has now become a factor in the case interview.

Mahan threatens to further dilute the Democratic vote, which is spread so thin that polling excluding Mahan has repeatedly ...

Nick Fugate, the CEC’s lead forecaster, said that uncertainty “has increased significantly” in the last few electricity ...

When the Trump administration changed the dietary guidelines for alcohol consumption, it fueled a debate over whether booze ...

Secretary General of the Nigerians in the Middle East and North Africa, Dr Anthonia Eddo, speaks to BIODUN BUSARI on ...

NextGen Pulse is designed as a living, responsive dataset of youth voices, capturing near-real-time narratives from young ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

No degree? That's not a problem with these jobs.